KSKensuke Sakata

Kensuke Sakata

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


Kensuke Sakata has a total of 61 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Graph neural network for predicting reentrant drivers in atrial digital twins

    by Shane Loeffler, Yash Lal, Alana Yee, Yazan Mohsen, Kensuke Sakata, Carolyna Yamamoto, Syed Yusuf Ali, Adityo Prakosa, Eugene G. Kholmovski, Natalia A. Trayanova

  • Open Access

    Clinical Vulnerability Refines Rhythm‐Related Outcomes in Older Patients Undergoing Pulmonary Vein Isolation for Atrial Fibrillation: An Observational Cohort Study

    by Yazan Mohsen, Jascha Fernholz, Lucas Steffens, Iryna Novikov, Shreeram Sabareesan, Ishan Vatsaraj, Kensuke Sakata, Moritz Knitter, Henning Horlitz, Marc Horlitz, et al.

    Introduction: Chronological age is often considered when selecting patients for atrial fibrillation (AF) ablation, but age alone may not identify which older patients are most likely to require recurrent rhythm‐related care after pulmonary vein isolation (PVI). Methods: We conducted a single‐center observational study of consecutive patients undergoing PVI. The principal registry cohort assessed the same‐center recurrence‐related rhythm‐intervention endpoint, defined as the first post‐index repeat PVI or electrical cardioversion. A nested active 2022 cohort assessed broader actively ascertained recurrence. Age was analyzed as < 50, 50–74, and ≥ 75. An exploratory elderly vulnerability score assigned one point each for documented persistent AF, heart failure, chronic kidney disease, and valve disease/surgery. Results: The registry cohort included 2559 patients and 580 same‐center rhythm‐intervention events. Event rates increased across age groups: 14.2% in patients aged < 50, 20.8% in those aged 50–74, and 29.8% in those aged ≥ 75. Age ≥ 75 was independently associated with higher risk versus age 50–74 in adjusted registry Cox analysis, HR: 1.35, 95% CI: 1.12–1.64, p = 0.002, after 90‐day blanking, HR: 1.37, 95% CI: 1.12–1.69, p = 0.002, and in the active cohort, HR: 1.46, 95% CI: 1.01–2.11, p = 0.042. Elderly Score 0 patients were not significantly different from patients aged 50–74 in registry analysis, aHR: 1.13, 95% CI: 0.79–1.63, p = 0.5, or active analysis, aHR: 1.01, 95% CI: 0.49–2.09, p = 0.975, whereas Score ≥ 2 identified higher event burden in both the registry cohort, aHR: 1.85, 95% CI: 1.45–2.35, p < 0.001, and active cohort, aHR: 1.95, 95% CI: 1.23–3.12, p = 0.005. Conclusion: Age ≥ 75 was associated with a higher rate of same‐center recurrence‐related rhythm interventions after PVI, but the risk varied substantially. Clinical vulnerability, not chronological age alone, may better inform counseling and selection of older patients.

  • Open Access

    Combined Unipolar and Bipolar Voltage Mapping at Redo Ablation After Cryoballoon Pulmonary Vein Isolation: Associations With Subsequent Arrhythmia Recurrence

    by Yazan Mohsen, Syed Yusuf Ali, Shreeram Sabareesan, Kensuke Sakata, Moritz Knitter, Johanna Hain, Henning Horlitz, Lucas Steffens, Ibrahim Antoun, Marc Horlitz, et al.

  • Transmural heterogeneity in 3D fibrosis distribution is associated with endo‐epicardial electrical dyssynchrony in persistent atrial fibrillation

    by Syed Yusuf Ali, Yazan Mohsen, Shreeram Sabareesan, Shane Loeffler, Carolyna Yamamoto, Adityo Prakosa, Eugene G. Kholmovski, David Spragg, Hugh Calkins, Kensuke Sakata, et al.

    Despite the established role of endo‐epicardial dissociation in the substrate of persistent atrial fibrillation (PsAF), the underlying mechanisms within the 3D atrial wall that lead to this phenomenon are not fully understood. Using personalized digital twin (DT) technology, we investigated the association between 3D transmurally heterogenous fibrosis architecture and endo‐epicardial dissociation in PsAF. LGE‐MRI scans from 21 PsAF patients were used to generate bi‐atrial DTs. Following virtual induction of reentry using programmed stimulation, a comparative analysis of the electrophysiological and structural properties of reentry‐sustaining regions (RRs, n = 91) against controls (non‐RRs, n = 73) was performed. RRs exhibited significantly greater endo‐epicardial dissociation compared to non‐RRs, evidenced by larger differences in median transmembrane potential (60.1 vs . 4.1 mV, P  < 0.001) and local activation times (55 vs . 14.9 ms, P  < 0.001). Lower dice similarity coefficient (DSC) was observed in RRs compared with non‐RRs (median 0.731 (IQR 0.660–0.812) versus 0.880 (IQR 0.642–0.971), respectively; P = 0.0009). In multivariable logistic regression, fibrosis percentage, transmembrane voltage difference, and DSC were independently associated with RR status, whereas LAT difference was not. Our findings reveal that 3D transmurally heterogeneous fibrosis architecture is associated with endo‐epicardial electrical dissociation in PsAF, with increased dissociation observed in regions harbouring reentrant circuits. Our findings advance the mechanistic understanding of PsAF arrhythmogenesis and provide a rationale for developing novel mapping and ablation strategies that account for the transmural complexity of the atrial substrate. image Key points: Persistent atrial fibrillation (PsAF) remains a significant clinical challenge, often marked by high rates of post‐ablation recurrence. While endo‐epicardial dissociation is a known factor in the PsAF substrate, the underlying mechanisms within the 3D atrial wall that lead to this phenomenon remain incompletely understood. In this study, we utilized personalized digital twin technology derived from LGE‐MRI scans of 21 patients to investigate the association between transmurally heterogeneous fibrosis and endo‐epi electrical dissociation. Our findings reveal that 3D transmurally heterogeneous fibrosis architecture is associated with endo‐epicardial electrical dissociation in PsAF. In multivariable analysis, fibrosis percentage, transmembrane voltage difference, and DSC were independently associated with reentrant activity. This work not only advances the mechanistic understanding of PsAF arrhythmogenesis but also suggests that successful clinical ablation strategies must account for the full 3D complexity of the atrial wall to target hidden intramural and epicardial pathways.

  • Open Access

    Documented Obstructive Sleep Apnea, Cardiometabolic Phenotype, and Rhythm‐Related Outcomes After Atrial Fibrillation Ablation: An Observational Cohort Study

    by Yazan Mohsen, Iryna Novikov, Shreeram Sabareesan, Kensuke Sakata, Moritz Knitter, Henning Horlitz, Lucas Steffens, Marc Horlitz, Ibrahim Antoun, Florian Stöckigt

    Background: Obstructive sleep apnea syndrome (OSAS) is common in atrial fibrillation (AF) and may influence AF phenotype and post‐ablation recurrence. We aimed to determine whether documented OSAS identifies a distinct clinical phenotype and whether it is associated with post‐ablation rhythm‐related outcomes. Methods: We performed a single‐center observational study with two overlapping cohorts. The principal registry cohort comprised 2559 patients with first AF ablation with pulmonary vein isolation (PVI) treated between November/2021 and July/2025. Its primary endpoint was the same‐center rhythm‐intervention endpoint, defined as the first post‐index repeat PVI or electrical cardioversion at the study center. A 7‐day Holter was scheduled 90 days after ablation. The nested active 2022 cohort comprised 666 AF/PVI patients. Results: Documented OSAS was present in 268 of 2559 registry patients, 10.5%, and in 66 of 652 patients with known OSAS status in the active subset, 10.1%. Documented OSAS was associated with higher BMI, more obesity, hypertension, diabetes, persistent AF, higher triglycerides and liver enzymes, and lower HDL cholesterol. In the registry cohort, the same‐center rhythm‐intervention endpoint occurred in 59/268 patients with documented OSAS (22.0%) and 521/2291 without documented OSAS (22.7%; p = 0.788). Documented OSAS was not associated with the registry endpoint after adjustment (OR: 0.87, 95% CI: 0.63–1.21; p = 0.411). In the active 2022 cohort, recurrence occurred in 16/32 patients with documented OSAS (50.0%) and 167/302 without documented OSAS (55.3%; p = 0.581). Adjusted Cox analysis also showed no independent documented OSAS (HR: 1.08, 95% CI: 0.61–1.94; p = 0.786). Conclusion: Documented OSAS identified an adverse cardiometabolic AF ablation phenotype but was not independently associated with same‐center rhythm interventions.

  • Open Access

    Relationships between three-dimensional fibrosis distribution, atrial adiposity, and voltage abnormalities associated with persistent atrial fibrillation

    by Kensuke Sakata, Adityo Prakosa, Carolyna A P Yamamoto, Syed Yusuf Ali, Yazan Mohsen, Shane Loeffler, Eugene G Kholmovski, Joseph E Marine, Hugh Calkins, David D Spragg, et al.

    Persistent atrial fibrillation (PsAF) is often refractory to pulmonary vein isolation, a well-established AF treatment, owing to the fibrosis-remodeled substrates sustaining reentries. Three-dimensional fibrosis distribution and atrial adiposity have been found to be essential contributors to PsAF arrhythmogenesis. We aimed to utilize late gadolinium enhancement (LGE)-MRI-derived personalized heart digital twins (DTs)—a recent promising tool for non-invasively assessing patient arrhythmogenesis—as well as contrast-enhanced cardiac computed tomography (CCT) images and electroanatomic maps (EAMs) to investigate relationships between fibrosis distribution, including endo–epi differences, adiposity infiltration, and electrophysiological abnormalities, and their influence on PsAF arrhythmogenic substrate. DTs incorporating fibrosis distribution were generated from consecutive PsAF patients’ LGE-MRIs. Using rapid pacing, potential locations attracting reentries (LRs) were identified in DTs. CCTs were used to segment adipose tissue within pericardial sac and evaluate the distance from endocardial surface to closest adipose tissue (DEnCA). Bipolar- and unipolar-low-voltage area fractions (LVFs) were extracted from EAMs. Volumetric fibrosis fraction (FF) and surface FF on endocardial and epicardial surfaces at LRs and non-LRs were analyzed in relation to DEnCA and LVF. In 22 patients, adipose tissue volume correlated with BMI and CHA2DS2-VASc and, together with atrial-FF, predicted number of LRs. At LRs and non-LRs, while volumetric-FF was the sole determinant of LR classification, volumetric-FF correlated with endocardium-predominant fibrosis and bipolar-LVF. Endocardium-predominant fibrosis was independently linked to DEnCA. This study highlights the complex interactions between structural features, such as three-dimensional fibrosis distribution and atrial adiposity infiltration, electrophysiological features, and PsAF arrhythmogenesis.


  • Arrhythmogenic substrates in atrial fibrillation and the role of ablation lesions: a longitudinal biatrial digital twin study

    by Carolyna Yamamoto, Kensuke Sakata, Syed Yusuf Ali, Shane Loeffler, Adityo Prakosa, Brock Tice, Eugene G Kholmovski, Natalia A Trayanova

    Aims: Arrhythmogenic fibrotic substrates facilitate reentrant activity in the atria, contributing to the perpetuation of atrial fibrillation (AF). Catheter ablation may disrupt existing reentrant pathways but can also create new ones. This longitudinal study aimed to assess whether post-ablation AF recurrence is associated with incomplete elimination of native arrhythmogenic substrates or emergence of new arrhythmogenic substrates created by ablation lesions, addressing important questions in current AF management: why some patients experience recurrence post-ablation while others do not, and whether ablation lesions themselves contribute to post-ablation arrhythmogenesis. Methods and results: Biatrial digital twins (DTs) derived from pre- and post-ablation contrast-enhanced magnetic resonance imaging were used to evaluate the arrhythmogenic propensity of the fibrotic substrate—quantified by potential reentry-sites (PRs) and a vulnerability index (VI) reflecting reentry inducibility. Pre- and post-ablation DT pairs were generated for 11 patients who experienced AF recurrence (R-DTs) and 11 who did not (N-DTs). In total, 58 pre-ablation PRs and 32 post-ablation PRs were detected, with a nearly even distribution of PRs between the left atrium (LA) and right atrium (RA) both pre- and post-ablation. Pre-ablation VI was similar between N-DTs and R-DTs; however, post-ablation VI was significantly higher in R-DTs (P = 0.015). N-DTs exhibited a marked reduction in PRs following ablation, whereas R-DTs did not (P = 0.017). Both groups had few residual PRs from pre- to post-ablation, but R-DTs had many newly emergent PRs. In R-DTs, emergent PRs in the RA were accompanied by a post-ablation increase in RA fibrotic burden. In the LA, where lesions were delivered, all post-ablation reentries anchored around ablation-induced scar (ScAReentries). ScAReentries were significantly more inducible than those occurring within fibrotic substrate and were nearly three times more prevalent in R-DTs, accounting for the elevated post-ablation VI. Conclusion: In DTs, emergent PRs in both atria underlie AF recurrence post-ablation, with ablation itself creating some PRs of high arrhythmogenic propensity.


  • SegBAW-Net: Segmentation of Bi-Atria and Wall Network Offering Valuable Insights into Challenge Data

    by Arthur L. Lefebvre, Ishan Vatsaraj, Carolyna A. P. Yamamoto, Kensuke Sakata, Brock Tice, Natalia A. Trayanova, Eugene G. Kholmovski


  • Open Access

    Assessing the arrhythmogenic propensity of fibrotic substrate using digital twins to inform a mechanisms-based atrial fibrillation ablation strategy

    by Kensuke Sakata, Ryan P. Bradley, Adityo Prakosa, Carolyna A. P. Yamamoto, Syed Yusuf Ali, Shane Loeffler, Brock M. Tice, Patrick M. Boyle, Eugene G. Kholmovski, Ritu Yadav, et al.

    Atrial fibrillation (AF), the most common heart rhythm disorder, may cause stroke and heart failure. For patients with persistent AF with fibrosis proliferation, the standard AF treatment—pulmonary vein isolation—has poor outcomes, necessitating redo procedures, owing to insufficient understanding of what constitutes good targets in fibrotic substrates. Here we present a prospective clinical and personalized digital twin study that characterizes the arrhythmogenic properties of persistent AF substrates and uncovers locations possessing rotor-attracting capabilities. Among these, a portion needs to be ablated to render the substrate not inducible for rotors, but the rest (37%) lose rotor-attracting capabilities when another location is ablated. Leveraging digital twin mechanistic insights, we suggest ablation targets that eliminate arrhythmia propensity with minimum lesions while also minimizing the risk of iatrogenic tachycardia and AF recurrence. Our findings provide further evidence regarding the appropriate substrate ablation targets in persistent AF, opening the door for effective strategies to mitigate patients’ AF burden.


  • Open Access

    The spatiotemporal electrogram dispersion ablation targeting rotors is more effective for elderly patients than non‐elderly population

    by Kensuke Sakata, Tomomi Tanaka, Soichiro Yamashita, Masanori Kobayashi, Mitsuaki Ito, Kohei Yamashiro

    Background: Modulating atrial fibrillation (AF) drivers has been proposed as one of the effective ablation strategies for non‐paroxysmal AF (non‐PAF). However, the optimal non‐PAF ablation strategy is still under debate because the exact mechanisms of AF persistence including focal activity and/or rotational activity, are not well‐understood. Recently, spatiotemporal electrogram dispersion (STED) assumed to indicate rotors in the form of rotational activity is proposed as an effective target for non‐PAF ablation. We aimed to clarify the effectiveness of STED ablation for modulating AF drivers.Methods: STED ablation plus pulmonary vein isolation was applied in 161 consecutive non‐PAF patients not undergoing previous ablation. STED areas within the entire left and right atria were identified and ablated during AF. After the procedures, the STED ablation's acute and long‐term outcomes were investigated.Results: (1) Despite a more effective acute outcome of the STED ablation for both AF termination and non‐inducibility of atrial tachyarrhythmias (ATAs), Kaplan–Meier curves showed that the 24‐month freedom ratio from ATAs was 49%, which resulted from the higher recurrence ratio of atrial tachycardia (AT) rather than AF. (2) A multivariate analysis showed that the determinant of ATA recurrences was only a non‐elderly age, not long‐standing persistent AF, and an enlarged left atrium, which were conventionally considered as key factors.Conclusions: STED ablation targeting rotors was effective in elderly non‐PAF patients. Therefore, the main mechanism of AF persistency and the component of the fibrillatory conduction might vary between elders and non‐elders. However, we should be careful about post‐ablation ATs following substrate modification.